ReviewFrontiers in immunology2025
From ketogenic metabolism to targeted therapeutics: current advances in β-hydroxybutyrylation.
Fangshuai Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ReviewFrontiers in immunology2025
Fangshuai Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.